Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients who have provided written consent of their own free will. 2) Males and females aged 20 years or older and under 80 years at the time of consent. 3) Patients diagnosed with type 2 diabetes. 4) Patients with an HbA1c value of 6.5% or higher within 37 days prior to obtaining consent.
Exclusion criteria
Exclusion criteria: 1) Patients with cognitive impairment who cannot fully understand the purpose or methods of this study. 2) Patients who started diabetes medications within 5 months prior to obtaining consent. 3) Patients who had a change in diabetes medications within 2 months prior to obtaining consent. 4) Patients undergoing insulin therapy. 5) Patients scheduled for surgery during the study period. 6) Patients with hypersensitivity to dietary fiber or a history of adverse reactions to dietary fiber intake. 7) Patients with severe gastrointestinal symptoms or gastrointestinal diseases. 8) Women who are breastfeeding, pregnant, or have a positive pregnancy test, and women who wish to become pregnant during the study period. 9) Other patients deemed unsuitable as study subjects by the principal or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The gut microbiota at the , particularly the proportion of Akkermansia in the total gut bacteria. | — |
Secondary
| Measure | Time frame |
|---|---|
| Gut microbiota 90 days after consuming the test food HbA1c 90 days after consuming the test food Short-chain fatty acids 90 days after consuming the test food | — |
Contacts
Director